Share Price:

APNASPENAspen Pharmacare Hldgs217010 (0.00%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

CNBC Exclusive with Aspen CEO Stephen Saad

Aspen Pharmacare billionaire Steven Saad opens up with the inside story of the fall of his shares. Exclusive on CNBC Africa first in business worldwide.

CNBC Exclusive with Aspen CEO Stephen Saad from Aspen Pharmacare Pty Limited on Vimeo.

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.